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Increase in vascular permeability is a conclusive response in the progress of inﬂammation. Under controlled conditions, leu-
kocytes are known to migrate across the vascular barriers to the sites of inﬂammation without severe vascular rupture. However,
when inﬂammatory state becomes excessive, the leakage of blood components may occur and can be lethal. Basically, vascular
permeability can be analyzed based on the intensity of blood outﬂow. To evaluate the amount and rate of leakage in live mice, we
performed cremaster muscle exteriorization to visualize blood ﬂow and neutrophil migration. Using two-photon intravital
microscopy of the exteriorized cremaster muscle venules, we found that vascular barrier function is transiently and locally
disrupted in the early stage of inﬂammatory condition induced by N-formylmethionyl-leucyl-phenylalanine (fMLP). Mea-
surement of the concentration of intravenously (i.v.) injected Texas Red dextran inside and outside the vessels resulted in clear
visualization of real-time increases in transient and local vascular permeability increase in real-time manner. We successfully
demonstrated repeated leakage from a target site on a blood vessel in association with increasing severity of inﬂammation.
,erefore, compared to other methods, two-photon intravital microscopy more accurately visualizes and quantiﬁes vascular
permeability even in a small part of blood vessels in live animals in real time.
1. Introduction
Control of vascular permeability allows leukocyte migration,
provides nutrition, and maintains homeostasis of the body
[1]. Due to its importance, therefore, vascular permeability
has been actively investigated in the ﬁeld of medical science
[2–4]. Various stimuli act on endothelial cells and adjust the
tightness of the vascular barrier by remodeling actins [3].
VE-cadherin, which is only expressed in the epithelial cell,
and JAM-1 are key factors in vascular hemostasis and an-
giogenesis [5, 6]. Metastasis of cancer cells is strongly as-
sociated with vascular integrity since a highly permeable
endothelial barrier induces angiogenesis, which eventually
supports the dissemination of tumor cells [7–9]. Despite
numerous studies, detailed steps of controlling mechanisms
about vascular permeability have not been uncovered.
,erefore, we prepared cremaster muscle of mice in order to
observe the changes in vascular integrity in acute in-
ﬂammatory conditions. ,e cremaster muscle was treated
with bacterial chemoattractant, fMLP, and two-photon in-
travital imaging of cremaster muscle venules was conducted
for more than 3 hours. fMLP was used to recruit neutrophils
along the cremaster vessels [10, 11]. ,e major premise of
this study was that neutrophils activated by fMLP would
increase the secretion of vascular endothelial growth factor
A (VEGF-A); therefore, vascular integrity would be de-
creased by cytoskeletal contraction [2, 12]. We were able to
detect increased vascular permeability with this methodol-
ogy; we analyzed the characteristics of this phenomenon by
comparing several targeted locations on inﬂamed vessels.
Morphological changes in leukocytes and the intensity of
blood ﬂow were also evaluated.
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2. Materials and Methods
2.1. Mice. LysM-GFP mice were used for two-photon in-
travital imaging [13, 14]. ,e animal and experimental
facilities were located at Yonsei University College of
Medicine’s speciﬁc pathogen-free zone. Only heterogenetic
mice (GFP/+) were used for experiments. ,e institutional
review board of Yonsei University College of Medicine
approved the study.
2.2. Cremaster Exteriorization for Intravital Imaging. ,e
mouse cremaster muscle was chosen for intravital imaging,
as it can be locally stimulated by exposure to fMLP after
exteriorization [10]. Mice were anesthetized with a Zoletil
and Rompun mixture (3 : 2) via intramuscular injection
(10mg/kg). Texas Red dextran was injected via i.v. injection
in order to label the blood ﬂow. After a few seconds, mice
were placed on the cremaster imaging chamber and ﬁrmly
ﬁxed with surgical tape. Body hair was removed with a razor
and shaving cream along the scrotum and testes. ,e upper
skin of the scrotal sac was retracted with forceps and secured
with insect pins. After this procedure, the mouse skin was
ready for exposure. From this point, 1x phosphate-buﬀered
saline (PBS) preheated to around 34–35°C was always
running inside the chamber sink in order to maintain the
temperature and humidity of the cremaster tissue. Attach-
ment of a yellow tip to the PBS tube was useful for con-
tinuous water irrigation. Under stereoscopic microscopy,
the ventral surface of the pinned scrotal sac was incised. ,e
testicle was removed through the sac with mild pressure on
the abdominal cavity. Connective tissues between the scrotal
skin and cremaster muscle were gently detached, and the
separated scrotal skin was everted to avoid disturbing the
cremaster muscle preparation. Finally, the cremaster muscle
was gently spread on the silicone bed with several pins.
Before imaging, the prepared cremaster muscle was washed
once again with preheated 1x PBS in order to obtain
a clear view.
2.3. Two-Photon Intravital Imaging of Inﬂamed Cremaster
Muscle Venules. After cremaster surgery, vessel in-
ﬂammation was induced with drops of fMLP (1 µM). Mul-
tiphoton microscopy (LSM 7 MP; Zeiss) with two-photon
excitation (3 colors: blue, green, and red. Each of the three
channels has an emission wavelength of 420–475 nm, 500–
550 nm, and 565–610 nm.) was used at a wavelength of
880–900 nm. Second harmonic generation was represented by
blue, and Texas Red dextran and neutrophils were visualized
with red and green, respectively.MaiTai Deep See laser system
(Spectra-Physics) which detects wavelengths from 690 to
1040 nmwas used for excitation. Video resolution was ﬁxed at
512× 512 pixels.
2.4. Vascular Permeability Analysis. Vascular permeability
or leakage was measured using an arbitrary unit, a.u. An
intact vessel with zero leakage was set as the baseline for this
unit (Figure 1). Absolute values were used to represent
intensity in % and blood leakage volumes (Figures 2 and 3).
2.5. Imaging Data Analysis. ZEN operating software (Carl
Zeiss) was used for operating software of two-photon mi-
croscope and data gathering. Volocity (PerkinElmer) was
used for tracking of neutrophils and vascular permeability.
Graphs were drawn using Prism Software (GraphPad).
3. Results
3.1. Angiorrhexis Is a Local and Transient Event throughout
a Blood Vessel during Inﬂammation. fMLP is a bacterial
chemoattractant used to induce an inﬂammatory state, in
which neutrophils inﬁltrate across blood vessels in damaged
or infected interstitium; this may induce vascular disruption
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Figure 1: Cremaster surgery and intravital imaging of inﬂamed cremaster vessel. (a) (I),e body of the mouse was ﬁxed in a chamber, using
surgical tape, with traction on the scrotum using suture thread. (II),e scrotumwas cut with scissors after ﬁlling the chamber with sterile 1x
PBS. (III) ,e epidermis in the scrotum was cut along its edge. (b, c) Changes in vessel permeability with time (min) were observed using
intravital imaging. Vascular leakage was measured as an arbitrary unit. An intact vessel with zero leakage was set as the baseline for this unit.
A graph of vascular leakage shows local and transient increase in blood permeability. Scale bar: 30 µm. See Video 1.
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[15–17]. ,e mouse cremaster muscle was prepared for this
experiment since a few drops of fMLP can be directly applied
to induce vascular inﬂammation (Figure 1(a)). We hy-
pothesized that fMLP-induced inﬂammation would lead to
neutrophil inﬁltration and disruption of the vascular barrier
in whole blood vessels. However, when fMLP was evenly
applied to the exteriorized cremaster muscle, vascular leakage
only increased in part of the blood vessel (Figure 1(b) and
Video 1). ,us, disruption did not develop simultaneously in
the entire inﬂamed vessel. On the contrary, vascular leakage
occurred locally, and the intensity varied signiﬁcantly between
intact and damaged vessel walls (Figure 1(c)). In addition,
neutrophil recruitment was only observed near the site of
vessel wall disruption (S2 in Figure 2(a) and Video 2), and
only a few neutrophils were detected near the intact vessel
structures (S1 in Figure 2(a) and Video 2). Interestingly,
neutrophils in S2 were attached in a row at the outer surface of
the weakened vessel, as if supporting the unstable membrane.
Comparison of S1 and S2 clearly showed diﬀerences in in-
ﬂammation progression. Indeed, the change in background
intensity, namely, the black space in Figure 2(a), showed that
blood leakage was more intense at S2 than at S1 (Figure 2(b)).
,erefore, even though it is known that neutrophil inﬁltration
does not coincide with vascular leakage at the same site in
a blood vessel [18, 19], neutrophil adhesion to the abluminal
side could induce vascular leakage at a delayed time point
following inﬁltration at the same site. As intravital time-lapse
imaging was performed in live animals, shaking occasionally
occurred during image capture. ,is could cause cremaster
muscle contraction and negligible variation in Texas Red
intensity, as indicated by the arrow in S1 in Figure 2(b).
3.2. Repetitive and Transient Leakage Occurs at a Consistent
Point on the Inﬂamed Blood Vessel. Vascular leakage is
a transient and local event in the blood vessel under in-
ﬂammation. ,us, a point on the stimulated vessel can be
more rapidly disrupted than another site on the same
stimulated vessel, as shown in Figures 1(b) and 2(a). After
detection of vascular leakage at a vulnerable point on the
inﬂamed vessel (S2 in Figure 2(a)), we further tracked the
target area to quantify blood outﬂow using a rainbow scale.
,e principle of the rainbow scale is similar to that of the
contour line; when the rate of leakage is high, the area
appears red. Areas with relatively low rates of leakage appear
blue to green. From the rainbow scale-based tracking of S2,
we observed that there were two separate disruptive events at
the same site on the vessel (Figure 3(a)). A period of mild
vascular leakage was observed at one site, with outﬂow of
about 75 μm3 of dextran at peak for 48–50min. Once
outﬂow began, the Texas Red dextran quickly and widely
spread across the interstitial area and became undetectable
on two-photon intravital imaging. Interestingly, after an
interval of 5min, another more signiﬁcant leakage event
occurred at the same site on the blood vessel. ,e peak
volume of the second leakage event reached 180 μm3
(Figure 3(b)). Based on the graphical display of vascular
leakage, blood was suddenly extruded from this particular
site on the vessel, and the second extrusion phase was more
signiﬁcant than the ﬁrst. ,us, leakage from inﬂamed vas-
culature is a discontinuous event and may repeatedly occur
depending on the progress of inﬂammation. ,erefore, our
data veriﬁed that two-photon intravital microscopy can be
used as a precise tool for research on leakage at an individual
vascular level.
4. Discussion
Traditional in vitro methodologies used to study vascular
permeability include measurement of hydraulic
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Figure 2: Vascular leakage occurs at speciﬁc sites on a vessel despite uniform fMLP treatment. (a) Blood vessels are visualized with dextran,
and neutrophils appear green on the image. When fMLP was used to activate neutrophils, the site of leakage was designated as S2 and the
area where leakage did not occur was designated as S1 in the same blood vessel (blood leakage occurred at S2, with no apparent change in S1).
Scale bar: 30µm. See Video 2. (b) When leakage occurred at S1 and S2, blood was extruded and the intensity of red was increased.,e graphical
display compares the intensity at two areas at 44 to 60min in Video 2. At the time of initial imaging (arrow), the intensity of S1 is higher than that
of S2 because the background becomes reddish as overlap occurs due to motion during in vivo imaging. Graph B shows the percent intensity (%)
of blood ﬂow in the two areas, as measured by the leakage of dextran.
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conductivity, transendothelial electrical resistance, and al-
bumin transport [20]. However, these techniques are in-
adequate for replication of actual vascular condition and
disease models. In addition to the methods described above,
a human microvascular endothelial cell (hMVEC) assay is
used to reproduce an actual microvascular environment.
With this hMVEC assay system, scientists can directly apply
cytokines and growth factors such as interleukin-8 and
VEGF to induce inﬂammatory conditions that are similar to
an in vivo setting [21]. However, it is important to note that
almost every in vitro experiment shows greater permeability
levels compared to in vivo trials [20]. In vitro studies are
performed under precisely controlled conditions, whereas in
vivo studies are always aﬀected by complicated and con-
founding factors.
Vascular permeability assays in vivo using Evans blue dye
can be useful in overcoming the limitation of cellular and
membrane-based experiments. Intravenous injection of Evans
blue, a dye that binds to albumin, will circulate throughout the
animal body. Due to the impermeability of the endothelium to
albumin, Evans blue should remain inside the liver in the
control animal [22]. However, when vascular permeability is
increased with inﬂammatory stimulation, leakage of Evans
blue will be detected around aﬀected vessels and organs. For
example, Han et al. [23] were able to prove that angioedema is
mediated by bradykinin via Bk2R by comparing the intensity
of Evans blue concentration in the digested mouse ear and
intestinal tissues. A vascular permeability assay, however,
cannot directly show real-time leakage of blood. Com-
bining our cremaster ﬂuorescence analysis and Evans blue dye
assaymay compensate for the shortcomings of thesemethods.
In this study, we performed two-photon intravital mi-
croscopy to measure how vascular leakage occurs at the
subvascular level under fMLP-induced inﬂammatory con-
ditions. ,e cremaster muscle is useful for intravital ﬂuo-
rescent imaging since it can be easily exteriorized and is
transparent. We investigated how blood vessels are dis-
rupted and vascular leakage occurs during acute inﬂam-
mation in correlation with neutrophil inﬁltration.,erefore,
we used LysM-GFP mice, in which neutrophils were clearly
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Figure 3: Leakage occurs in a repetitive and consistent manner. (a) ,e ﬁrst image without blood leakage in S2 was set as a control
condition. Color change shows the amount of leakage. Vessels appear magenta and blood ﬂow is seen with rainbow colors. It is apparent that
two disruptive events occurred within 16min. A much greater amount of leakage was observed during the second disruptive event.
(b) Vascular permeability was visually demonstrated, and the graph quantitatively shows about twice as much leakage.,e graphical display
is consistent with transient leakage from the same site. Endothelial barrier disruption did not always result in leakage. Two arrows in the
ﬁgure indicate that leakage has occurred. Graph B shows the volume of leakage measured according to site. Scale bar: 10 µm.
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visualized by detection of green ﬂuorescence following in-
travenous injection of Texas Red dextran (70 kDa). Texas
Red dextran demonstrates a green color in the absence of
bleeding, with use of a long wavelength laser (880–900 nm).
,is wavelength rarely induces tissue phototoxicity or pho-
tobleaching. ,us, it was possible to perform intravital im-
aging at the same site for up to several hours without severe
photo-induced damage. When injected, dextran circulates
within and clearly outlines the vasculature. ,erefore, Texas
Red leakage is a marker of vascular disruption. We locally
induced an acute inﬂammatory state by treatment of the
exteriorized mouse cremaster muscle with fMLP. As precise
two-photon intravital imaging detects the concentration of
Texas Red dextran inside and outside blood vessels, we were
able to visualize how leakage occurs from any site on a blood
vessel in a living animal. ,erefore, this intravital imaging
method enables more accurate assessment of vascular leakage
in terms of time and location. As shown in our data, vascular
leakage is a local and transient event in a blood vessel during
acute inﬂammation. Use of intravital imaging to visualize
leakage of intravascular components under inﬂammatory
conditions makes it possible to detect subvascular level dis-
ruption of the blood vessel in the target organ. In combination
with further research on signaling mechanisms such as cy-
tokine interactions among cells and receptors, this ﬂuorescent
intravital approach can provide essential information for
development of therapeutic methods for diseases associated
with blood vessel malfunction.
Data Availability
,e data used to support the ﬁndings of this study are
available from the corresponding author upon request.
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